Medicine Name:
Juvobin 40 Injection
Required Status:
Prescription Required
Type of Selection:
0.4 ml in 1 prefilled syringe
Manufacturer:
La Renon Healthcare Pvt Ltd
Salt:
Darbepoetin alfa (40mcg),
MRP:
₹2299
Uses:
Treatment of Anemia due to chronic kidney disease,Treatment of Anemia due to cancer chemotherapy,
Alternate Medicines:
Ibidarb 40mcg Injection,Darbatitor 40mcg Injection,Dargen 40 Injection,Darcept 40 Injection,Darbecure 40 Injection,
Side Effects:
High blood pressure,Hypersensitivity,
How to Use:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Chemical Class:
Amino Acids, Peptides Analogues
Habit Forming:
No
Therapeutic Class:
BLOOD RELATED
Action Class:
Erythropoiesis-stimulating agent (ESA)
. Please note, this information is for educational purposes only and not intended as medical advice.
Juvobin 40 Injection
Juvobin 40 Injection is a prescription medication that contains the active ingredient Darbepoetin alfa (40mcg). It is manufactured by La Renon Healthcare Pvt Ltd and is available in prefilled syringes with a concentration of 0.4 ml per syringe.
Pharmacological Properties
Darbepoetin alfa is a synthetic form of erythropoietin, a hormone that stimulates the production of red blood cells in the body. It works by promoting the growth and maturation of red blood cell precursors in the bone marrow, leading to an increase in red blood cell count and hemoglobin levels.
Indications
Juvobin 40 Injection is commonly used for the treatment of anemia due to chronic kidney disease and anemia caused by cancer chemotherapy.
Contraindications
Juvobin 40 Injection is contraindicated in patients with uncontrolled hypertension, known hypersensitivity to Darbepoetin alfa or any other components of the formulation, and in patients with pure red cell aplasia due to erythropoiesis-stimulating agents.
Dosage
The dosage of Juvobin 40 Injection should be individualized based on the patient’s hemoglobin level and response to treatment. It is typically administered by a healthcare professional through injection. Do not self-administer this medication.
Side Effects
Common side effects of Juvobin 40 Injection may include high blood pressure and hypersensitivity reactions. It is important to report any adverse reactions to your healthcare provider.
Drug Interactions
There may be potential drug interactions with other medications that can affect the efficacy or safety of Juvobin 40 Injection. It is important to inform your healthcare provider about all the medications you are currently taking.
Patient Counseling
Prior to starting Juvobin 40 Injection, patients should be counseled on the proper administration technique, possible side effects, and the importance of regular monitoring of hemoglobin levels. Patients should also be educated on the signs and symptoms of hypersensitivity reactions.
Clinical Evidence
Clinical studies have demonstrated the efficacy and safety of Darbepoetin alfa in the treatment of anemia associated with chronic kidney disease and cancer chemotherapy. Regular monitoring of hemoglobin levels and appropriate dose adjustments are essential for optimal treatment outcomes.
Frequently Asked Questions
1. Can I self-administer Juvobin 40 Injection?
No, Juvobin 40 Injection should only be administered by a healthcare professional. Do not attempt to self-administer this medication.
2. What should I do if I experience high blood pressure while taking Juvobin 40 Injection?
If you experience high blood pressure or any other concerning side effects, contact your healthcare provider immediately for further evaluation and guidance.
3. Are there any alternative medicines to Juvobin 40 Injection?
Yes, some alternative medicines to Juvobin 40 Injection include Ibidarb 40mcg Injection, Darbatitor 40mcg Injection, Dargen 40 Injection, Darcept 40 Injection, and Darbecure 40 Injection. Consult your healthcare provider for more information.
4. Is Darbepoetin alfa habit-forming?
No, Darbepoetin alfa is not habit-forming. It is a therapeutic agent used to stimulate the production of red blood cells in specific medical conditions.
5. How does Darbepoetin alfa differ from natural erythropoietin?
Darbepoetin alfa is a synthetic form of erythropoietin that has been modified to have a longer half-life in the body, allowing for less frequent dosing compared to natural erythropoietin.
Please note, this information is for educational purposes only and not intended as medical advice.
